Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of 3-month mortality after rtPA thrombolysis for acute ischemic stroke
ChiCTR-PRCH-11001279Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Sep 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: mortality. Started Sep 2010; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-PRCH-11001279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRCH-11001279.